MyBlood ApS: Financial statements 2023
CVR: 41668393
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MyBlood ApS (CVR 41668393) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -25,213 the year before. Equity in the 2023 report amounted to DKK 2,590. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 2,590
- Total Assets
- DKK 2,590
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MyBlood ApS has published its annual report for 2022. Gross profit came to DKK -25,000, and the net result was DKK -25,213.
About MyBlood ApS
MyBlood ApS is a Danish company of the type Anpartsselskab based in Vodskov, founded in 2020. The company is registered under the industry Fremstilling af instrumenter og udstyr til måling, afprøvning og navigation. The management consists of Christine Maria Røntved. The company is owned by Christine Maria Røntved and Auste Augustyte. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 2,590.